Business Context and Reporting Period
Company: SUMA Acquisition Corp (SUMA), a Cayman Islands exempted company and Special Purpose Acquisition Company (SPAC).
Reporting Period: Quarterly period ended March 31, 2026.
Status: The Company consummated its Initial Public Offering (IPO) on March 12, 2026. It is an early-stage, emerging growth company with no operating revenues. Its sole purpose is to effect a Business Combination with one or more target businesses.
Key Financial Metrics
| Metric | Value (as of/for period ended March 31, 2026) |
|---|---|
| Total Assets | $174,131,769 |
| Cash and Marketable Securities in Trust Account | $172,819,182 |
| Cash Outside Trust Account | $1,167,663 |
| Working Capital | $984,296 |
| Net Income | $152,021 |
| Operating Costs (G&A) | $167,161 |
| Interest Income (Trust Account) | $319,182 |
| Total Liabilities | $7,166,845 |
| Deferred Underwriting Fee | $6,900,000 |
| Shares Outstanding (Class A Public) | 17,250,000 |
| Shares Outstanding (Class B Founder) | 5,750,000 |
Material Changes vs. Prior Period
The reporting period represents the Company's first quarter of operations following its IPO on March 12, 2026. Consequently, financial metrics reflect a transition from a pre-IPO shell to a post-IPO SPAC:
- Assets: Increased from $67,658 (Dec 31, 2025) to $174,131,769, driven by the placement of $172,500,000 into the Trust Account.
- Equity: Shifted from a positive equity balance of $4,096 to a deficit of $(5,854,258) due to the classification of 17,250,000 Class A shares as temporary equity (subject to redemption) and the accretion of their carrying value to the redemption price.
- Liabilities: Increased from $63,562 to $7,166,845, primarily due to the recognition of the $6,900,000 deferred underwriting fee.
- Revenue/Income: The Company generated no operating revenue. Net income of $152,021 was derived entirely from interest earned on the Trust Account ($319,182) offset by general and administrative costs ($167,161).
Outlook, Risks, and Management Commentary
Business Combination Timeline: The Company has until March 12, 2028 (24 months from IPO) to consummate an initial Business Combination. Failure to do so will result in liquidation and redemption of Public Shares.
Liquidity: Management believes current cash outside the Trust Account ($1.17 million) is sufficient to fund operations for at least one year. The Company may seek Working Capital Loans from Sponsors (up to $1.5 million convertible) if needed.
Risks and Contingencies:
- Geopolitical Instability: Conflicts in Ukraine, the Middle East (U.S., Israel, Iran), and global trade policy changes (tariffs) may adversely affect the ability to identify or complete a Business Combination.
- Delisting Risk: If the Company fails to meet the Nasdaq 36-Month Requirement, its securities may be suspended and delisted.
- Extension Risk: Extending the Combination Period may require shareholder approval and could reduce the Trust Account balance via redemptions.
Investor Verification Checklist
- Trust Account Balance: Verify the current per-share redemption value ($10.02 as of March 31, 2026) and interest accruals.
- Deferred Fee Obligation: Confirm the $6.9 million deferred underwriting fee payable only upon a successful Business Combination.
- Share Structure: Note the 25% ownership stake held by Founder Shares (Class B) and the 1/5 Right attached to each Public Unit.
- Related Party Transactions: Review the $25,000/month administrative fee payable to the U.S. Sponsor and the outstanding $45,078 IPO Promissory Note.
- Extension Provisions: Understand the conditions under which the Company may extend the deadline beyond March 12, 2028, and the associated redemption rights for public shareholders.